Two physicians who co-founded Fullerton Healthcare Corporation have been hit with combined fines of S$160,000 for orchestrating a scheme involving falsified entertainment expense claims linked to more than S$211,000, Singapore's courts determined on Friday. Daniel Chan Pai Sheng and Michael Tan Kim Song, both aged 52, submitted inflated or entirely fabricated receipts over several years, though the proceeds were directed to a third party rather than enriching themselves—a factor that may have influenced the sentencing outcome.

The money channelled through the falsified claims was intended for Collin Chiew, a 58-year-old who previously served as chief executive of insurance broker Aon Singapore from January 2015 to July 2018. According to court documents, Chiew had approached Chan requesting financial assistance sometime around 2015, citing personal needs including funding for his children's education and housing expenses. Court records do not clarify whether Chiew ultimately received the full amount in question, though the scheme operated with explicit knowledge that funds were being diverted for his benefit.

Chan received the heavier penalty of S$135,000 after pleading guilty to five counts of falsifying accounting records. The extent of his involvement was substantially greater than his co-founder's—the claims he falsified totalled over S$336,000 when the legitimate expenses amounted to approximately S$125,000, creating an inflated discrepancy exceeding S$211,000. In contrast, Tan was fined S$25,000 for a single count of falsification of accounts, relating to one of Chan's charges. Tan's specific falsified claim was approximately S$82,000 against actual expenses of just over S$42,000, resulting in an inflation of nearly S$40,000.

The operational mechanics of the scheme reveal a sophisticated approach to document falsification. Starting in 2015, when Chan began travelling to Hong Kong roughly twice monthly on business for the healthcare group, he would coordinate with co-founder David Sin and an accomplice named Tei Chu Pink, aged 46, to arrange inflated or entirely fictitious Karaoke Television (KTV) entertainment receipts. Tei would fabricate these documents before Chan's trips. Once in Hong Kong, Chan would participate in genuine KTV outings where potential business investors were entertained, yet the receipts submitted upon his return to Singapore bore inflated amounts or reflected transactions that never occurred. In some instances, Chan made minimal payments or no payments at all at these establishments, instead collecting the pre-prepared false receipts from Tei.

The generated receipts would then be distributed to designated personnel within Fullerton Healthcare Corporation or its subsidiary Fullerton Health China, where they would be processed through corporate accounting systems as legitimate business expenses. This created a paper trail suggesting routine entertainment costs associated with business development activities. Court prosecutors noted that several of these fabricated claims proceeded with Tan's explicit knowledge and consent, establishing his complicity beyond mere passive awareness. The false documentation enabled the companies to release funds ostensibly reimbursing Chan for business entertainment, which were subsequently diverted to Chiew's personal benefit.

Interestingly, prosecutors pursued an alternative legal pathway regarding graft-related offences. The two co-founders faced accusations of corruption-linked crimes in addition to falsification charges, but the prosecution applied for a discharge not amounting to acquittal for all such charges, invoking prosecutorial discretion. District Judge Paul Quan granted this application, meaning the graft charges were formally set aside. However, this discharge carries significant implications—should new evidence or information emerge in future, prosecutors retain the authority to resurrect these charges against Tan and Chan, leaving the door permanently ajar for potential additional prosecution.

Both men have relinquished their former roles at the subsidiary companies. Tan previously held a directorship at Fullerton Healthcare Group, the original healthcare services provider established in 2010 that operated through a network of doctors and specialists while assisting clients with insurance claim processing. Chan held the position of president at Fullerton Health China, another subsidiary operating within the broader FHC structure. Their departures from these roles occurred following the investigation into the falsification scheme.

The resolution of the Tan and Chan matter follows an earlier case involving David Sin, the third co-founder of Fullerton Healthcare Corporation. Sin, aged 47, admitted guilt in August 2025 to six counts of falsifying accounts and received a fine of S$160,000—substantially matching the combined penalty imposed on his two co-founders despite facing double the number of charges. This parity in sentencing suggests the courts may have weighted the degree of personal financial benefit and the sophistication of the falsification scheme rather than simply tallying the volume of offences.

The case illuminates persistent vulnerabilities in corporate expense management and document verification within professional healthcare enterprises, particularly those operating across multiple jurisdictions. The scheme's multi-year duration—operating from 2015 through at least 2016 when Tan participated in a conspiracy to falsify a specific entertainment claim—indicates inadequate internal controls or audit mechanisms capable of detecting systematic receipt manipulation. For Malaysian businesses with regional operations, the case underscores the critical importance of robust expense verification protocols, independent auditing procedures, and segregation of duties between those authorising expenses and those processing documentation.

The severity of penalties imposed, despite the defendants not personally profiting, signals that Singapore's authorities regard the breach of fiduciary duty and corporate governance principles as sufficiently grave to warrant substantial fines. The fact that the money was channelled to assist a third party rather than filling the defendants' personal coffers did not substantially mitigate their culpability, suggesting courts view falsification of corporate records as inherently serious regardless of how the proceeds are ultimately distributed. Malaysian executives and healthcare administrators operating regionally should recognise that financial impropriety undertaken for ostensibly benevolent purposes—assisting colleagues experiencing personal hardship—receives no leniency under Singapore's criminal framework.

The broader implications for Southeast Asian business practice are substantial. Healthcare corporations, insurance brokers, and investment holding companies across the region frequently maintain offices in multiple countries and authorise significant entertainment and business development expenses. The Fullerton Healthcare case demonstrates that international operations do not protect actors from prosecution, and that falsifying documentation to facilitate cross-border fund transfers represents a serious criminal liability. Directors and senior managers must implement stringent verification requirements for all expense claims, particularly those involving overseas activities where oversight is inherently more challenging.